NCT05430685

Brief Summary

The purpose of this study was to compare the impact of 700 mg daily ashwagandha (Withania Somnifera) in healthy college students on sleep, stress and food cravings to healthy college students taking placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started May 2019

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 24, 2022

Completed
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

11 months

First QC Date

May 27, 2022

Last Update Submit

June 18, 2022

Conditions

Keywords

Ashwagandha

Outcome Measures

Primary Outcomes (3)

  • Impact of ashwagandha on Sleep

    Restorative Sleep Questionnaire is a 9-item validated scale assessing feelings and experiences about the participant's sleep and their perception of daytime consequences associated with their sleep patterns. Scores range from 0-100 where higher scores indicate better quality sleep.

    Change of restorative sleep quality at 30 days

  • Impact of ashwagandha on Perceived Stress

    Stress was assessed using the Perceived Stress Scale a 10-item validated questionnaire measuring the degree to which situations in participant's life were viewed as stressful. Questions addressed anxious thoughts, locus of control, and coping mechanisms. Scores range from 0-40 (higher scores indicate higher stress levels).

    Change of perceived stress at 30 days

  • Impact of ashwagandha on Food Cravings

    Eating behavior was assessed using the Food Cravings Questionnaire, a 15-item validated instrument assessing food behavior and appetite using Likert-scales related to intentions for eating, perceived control, hunger cues, emotional states, and guilt associated with cravings. Scores range between 15 and 90 (higher scores indicate more frequent and intense food cravings).

    Change of food cravings at 30 days

Secondary Outcomes (2)

  • Qualitative analysis of ashwagandha on college students across sleep, stress and food cravings.

    At 30 days

  • Daily check in qualitative analysis

    Up to 30 days

Study Arms (2)

Ashwagandha

EXPERIMENTAL

Generic name: ashwagandha root extract Dose form: Chloroform capsule Dose: 1 capsule 350 mg ashwagandha root extract Frequency: 2 times per day (one capsule in the morning, one capsule in the evening). Total: 700 mg ashwagandha root extract per day Duration: 30 days

Dietary Supplement: Ashwagandha

Placebo

PLACEBO COMPARATOR

Generic name: placebo Dose form: Glycerin equivalent weight to ashwagandha Dose: 1 capsule Frequency: one capsule, 2 times per day (one capsule in morning and one in evening) Duration: 30 dys

Other: Placebo

Interventions

AshwagandhaDIETARY_SUPPLEMENT

Intervention and placebo group each received a bottle of 60 capsules. Subjects were instructed to take one capsule in the morning and 1 capsule in the evening. Intervention group was getting 350 mg ashwagandha root extract per capsule (or 700 mg per day). Each intervention capsule delivered 2.5 mg withanolides with equivalence of 2,700 mg dry herb.

Also known as: Gaia Herbs, Withania somnifera
Ashwagandha
PlaceboOTHER

The Placebo group received the same type of bottle with similar looking capsules. Each person in the placebo group was instructed to take 1 capsule twice a day (2 capsules total). Capsules were filled with glycerin to the same weight as ashwagandha. Capsules were indistinguishable from each other.

Also known as: glycerin
Placebo

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsPeople of any gender identity were eligible
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Enrolled at the university

You may not qualify if:

  • sensitivity to nightshade vegetables;
  • peptic ulcer;
  • pregnant or expected to become pregnant in the near future;
  • breastfeeding;
  • had recent or planned surgery;
  • hypotensive;
  • diagnosed with diabetes;
  • and/or taking any of the following classes of medications: benzodiazepines, central nervous system depressants, diabetes medication, thyroid medication, immune suppressors, cardiovascular medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Colorado Springs

Colorado Springs, Colorado, 80918, United States

Location

Related Publications (2)

  • O'Connor J, Lindsay K, Baker C, Kirby J, Hutchins A, Harris M. The Impact of Ashwagandha on Stress, Sleep Quality, and Food Cravings in College Students: Quantitative Analysis of a Double-Blind Randomized Control Trial. J Med Food. 2022 Dec;25(12):1086-1094. doi: 10.1089/jmf.2022.0040. Epub 2022 Aug 18.

  • Baker C, Kirby JB, O'Connor J, Lindsay KG, Hutchins A, Harris M. The Perceived Impact of Ashwagandha on Stress, Sleep Quality, Energy, and Mental Clarity for College Students: Qualitative Analysis of a Double-Blind Randomized Control Trial. J Med Food. 2022 Dec;25(12):1095-1101. doi: 10.1089/jmf.2022.0042. Epub 2022 Aug 18.

MeSH Terms

Interventions

AshwagandhaGlycerol

Intervention Hierarchy (Ancestors)

Triose Sugar AlcoholsSugar AlcoholsAlcoholsOrganic ChemicalsCarbohydrates

Study Officials

  • Margaret Harris, PhD

    University of Colorado, Colorado Springs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The company (Gaia Herbs) prepared the intervention and placebo and had knowledge with Intervention A and B. Neither the investigators, coordinators, subjects or data analyst had knowledge of the group designation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups: one intervention, one placebo
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 27, 2022

First Posted

June 24, 2022

Study Start

May 29, 2019

Primary Completion

April 10, 2020

Study Completion

April 10, 2020

Last Updated

June 24, 2022

Record last verified: 2022-06

Locations